Article Title,Year,Volume,Issue,Page Range,Author
Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review,2006,26,5,247-255,Sharp
Effect of ivabradine a novel antianginal agent on driving performance: A randomized double-blind placebo-controlled trial in healthy volunteers,2009,29,5,339-348,Macher
Current topics in opioid therapy for pain management: addressing the problem of abuse,2013,33,7,459-468,Casty
Patterns of antidepressant use in Italy: therapy duration adherence and switching,2015,35,11,735-742,Fagiolini
Benzodiazepine use misuse and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995,2016,36,7,519-530,Fischer
Intentional drug overdose involving pregabalin and gabapentin: findings from the National Self-Harm Registry Ireland 2007-2015,2018,38,4,373-380,Arensman
Abuse-deterrent opioid formulations: a key ingredient in the recipe to prevent opioid disasters?,2018,38,7,573-577,Hagemeier
Efficacy and safety of subcutaneous esketamine in the treatment of suicidality in major depressive disorder and bipolar depression,2022,ePub,ePub,ePub,Lacerda
Newer antiseizure medications and suicidality: analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database,2023,ePub,ePub,ePub,Piper
Clinical pharmacokinetics of a massive overdose of carbamazepine and acute renal failure,1997,14,1,66-75,Vree
Depression during pregnancy: Overview of clinical factors,2004,24,3,157-179,Koren
Comment on "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression",2023,43,1,79-80,Wilkowska
Authors' Response to Comment on "Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression",2023,43,1,83-84,Lacerda
Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?,2017,37,8,713-727,Sani